Despite the availability of effective antihypertensive therapies, global blood pressure control rates remain unacceptably low. Contributing factors, such as low treatment adherence, therapeutic ...

LONDON — Building up its base of medicines for lung diseases, GSK said Wednesday it was buying the privately held firm 35Pharma for $950 million in cash. The centerpiece of the deal is an experimental ...

The deal hands GSK a drug it views as a potentially “best-in-class” therapy for blood pressure diseases like pulmonary arterial hypertension — the target of Merck’s fast-selling Winrevair.

Ace Therapeutics announced custom animal models of hypertension, designed to help understand hypertension pathogenesis ...

The hypertension drug rilmenidine has been found to slow aging in worms – an effect that, if it translates to humans, could one day help us live longer and stay healthier in old age. Rilmenidine ...

Callum Metcalfe O'Shea advises how to manage a middle-aged male patient with hypertension who is refusing to take his ...

A blockbuster drug is a best-selling medication earning over $1 billion annually. Learn about them and how they revolutionize ...

Quitting an energy drink habit helped a man lower his blood pressure when medicine could not. He was drinking eight energy drinks a day, far exceeding the recommended caffeine limit. After quitting ...

Introduction Hypertension programmes have expanded substantially in low-income and middle-income countries, yet treatment and control rates remain insufficient. Programme scale-up may lead to ...

He was in good shape, but relying on energy drinks changed things. Reviewed by Dietitian Emily Lachtrupp, M.S., RD Quitting an energy drink habit helped a man lower his blood pressure when medicine ...